Silicon Valley’s Unapproved ‘Godzilla’: The Retatrutide Phenomenon and the Testing Crisis It Created
Tech elites are injecting an unapproved triple agonist sourced from the grey market. Here’s why that’s an analytical nightmare—and what rigorous testing reveals.